Structural Basis for Defects of Keap1 Activity Provoked by Its Point Mutations in Lung Cancer

Padmanabhan, Balasundaram, Tong, Kit I., Ohta, Tsutomu, Nakamura, Yoshihiro, Scharlock, Maria, Ohtsuji, Makiko, Kang, Moon-Il, Kobayashi, Akira, Yokoyama, Shigeyuki, Yamamoto, Masayuki·2006·Molecular Cell
DOI 10.1016/j.molcel.2006.01.013

Cited by (749)

Items 401–500 of 749

  1. Anticancer Drug Metabolism: Chemotherapy Resistance and New Therapeutic Approaches
    Hanane Akhdar, Claire Legendre, Caroline Aninat, Fabrice More · 2012 · InTech eBooks
  2. Phytochemical Regulation of UDP-Glucuronosyltransferases: Implications for Cancer Prevention
    Misty R. Saracino, Johanna W. Lampe · 2007 · Nutrition and Cancer
  3. Activation of NRF2 by APE1/REF1 is redox-dependent in Barrett's related esophageal adenocarcinoma cells
    Kannappan Sriramajayam, Dunfa Peng, Heng Lu, Shoumin Zhou, Nadeem Sidiq Bhat, Oliver Gene McDonald, Jianwen Que, Alexander Zaika, Wael M. El-Rifai · 2021 · Redox Biology
  4. Triggers for the Nrf2/ARE Signaling Pathway and Its Nutritional Regulation: Potential Therapeutic Applications of Ulcerative Colitis
    Liu Hu, Lee J Johnston, Fenglai Wang, Xi Ma · 2021 · International Journal of Molecular Sciences
  5. Multifaceted Roles of the KEAP1–NRF2 System in Cancer and Inflammatory Disease Milieu
    Harit Panda, Huaichun Wen, Mikiko Suzuki, Masayuki P. Yamamoto · 2022 · Antioxidants
  6. Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1–Nrf2 Protein–Protein Interaction
    Fabio Begnini, Stefan Geschwindner, Patrik Johansson, Lisa Wissler, Richard J. Lewis, Emma Danelius, Andreas Luttens, Pierre G. Matricon, Jens Carlsson, Stijn Lenders et al. · 2022 · Journal of Medicinal Chemistry
  7. Antioxidant-induced INrf2 (Keap1) tyrosine 85 phosphorylation controls the nuclear export and degradation of the INrf2–Cul3–Rbx1 complex to allow normal Nrf2 activation and repression
    James W. Kaspar, Suryakant K. Niture, Anil K. Jaiswal · 2012 · Journal of Cell Science · Retracted
  8. Vitamin D Protects Against Alcohol‐Induced Liver Cell Injury Within an NRF2–ALDH2 Feedback Loop
    Hong Zhang, Lian Xue, Bingyan Li, Zengli Zhang, Shasha Tao · 2019 · Molecular Nutrition & Food Research
  9. Targeting mutated GTPase KRAS in tumor therapies
    Guangjin Fan, Linlin Lou, Zhendong Song, Xiaolei Zhang, Xiao‐Feng Xiong · 2021 · European Journal of Medicinal Chemistry
  10. Unraveling the Role of Reactive Oxygen Species in T Lymphocyte Signaling
    Karsten Gülow, Deniz Tümen, Philipp Heumann, Stephan A. Schmid, Arne Kandulski, Martina Müller, C Kunst · 2024 · International Journal of Molecular Sciences
  11. Hypomorph mutation-directed small-molecule protein-protein interaction inducers to restore mutant SMAD4-suppressed TGF-β signaling
    Cong Tang, Xiulei Mo, Qiankun Niu, Alafate Wahafu, Xuan Yang, Min Qui, Andrei A. Ivanov, Yuhong Du, Haian Fu · 2020 · Cell chemical biology
  12. Carcinogenesis and transcriptional regulation through Maf recognition elements
    Hozumi Motohashi, Masayuki P. Yamamoto · 2006 · Cancer Science
  13. New Insights into Oxidative and Reductive Stress Responses and Their Relation to the Anticancer Activity of Selenium-Containing Compounds as Hydrogen Selenide Donors
    Agnieszka Krakowiak, Sylwia Pietrasik · 2023 · Biology
  14. Nrf2 deficiency leads to behavioral, neurochemical and transcriptional changes in mice
    Hiroyuki Muramatsu, Fumiki Katsuoka, Katsuo Toide, Yusuke I. Shimizu, Shoji Furusako, Masayuki P. Yamamoto · 2013 · Genes to Cells
  15. Oncogenic transformation of mesenchymal stem cells decreases Nrf2 expression favoring in vivo tumor growth and poorer survival
    Juan Manuel Funes, Stephen R Henderson, Rachel Kaufman, James M. Flanagan, Mathew P. Robson, Barbara R. Pedley, Salvador Moncada, Chris Boshoff · 2014 · Molecular Cancer
  16. RETRACTED ARTICLE: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation
    Xuefen Xu, Xiaobo Zhang, Yi Zhang, Lin Yang, Yicheng Liu, Shaoliang Huang, Lu Lu, Ling‐Yi Kong, Zhiyu Li, Qinglong Guo et al. · 2017 · Scientific Reports · Retracted
  17. The multifaceted role of NRF2 in cancer progression and cancer stem cells maintenance
    Bo-Hyun Choi, Jin Myung Kim, Mi‐Kyoung Kwak · 2021 · Archives of Pharmacal Research
  18. Computational design of an epitope-specific Keap1 binding antibody using hotspot residues grafting and CDR loop swapping
    Liu, Xiaofeng, Taylor, Richard D., Griffin, Laura, Coker, Shu-Fen, Adams, Ralph, Ceska, Tom, Shi, Jiye, Lawson, Alastair D. G., Baker, Terry · 2017 · Scientific Reports
  19. Targeting Protein–Protein Interfaces with Peptides: The Contribution of Chemical Combinatorial Peptide Library Approaches
    Alessandra Monti, Luigi Vitagliano, Andrea Caporale, Menotti Ruvo, Nunzianna Doti · 2023 · International Journal of Molecular Sciences
  20. Hsp90 Interaction with INrf2(Keap1) Mediates Stress-induced Nrf2 Activation
    Suryakant K. Niture, Anil K. Jaiswal · 2010 · Journal of Biological Chemistry · Retracted
  21. Induction of monoamine oxidase A-mediated oxidative stress and impairment of NRF2-antioxidant defence response by polyphenol-rich fraction of Bergenia ligulata sensitizes prostate cancer cells in vitro and in vivo
    Suvranil Ghosh, Naibedya Dutta, Pinaki Banerjee, Rahul L. Gajbhiye, HOSSAINOOR RAHAMAN SARENG, Prachi Kapse, Srabani Pal, Lyudmila G. Burdelya, Narayan Chandra Mandal, V. Ravichandiran et al. · 2021 · Free Radical Biology and Medicine
  22. The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and β-TrCP-NRF2 interactions in cancer chemoresistance
    Rohini Srivastava, Raquel Fernández-Ginés, José Antonio Encinar, Antonio Cuadrado, Geoffrey Wells · 2022 · Free Radical Biology and Medicine
  23. Renal protection by 3H-1,2-dithiole-3-thione against cisplatin through the Nrf2-antioxidant pathway
    Hyun-Min Park, Jeong‐Min Cho, Hyang‐Rim Lee, Gi-seoung Shim, Mi‐Kyoung Kwak · 2008 · Biochemical Pharmacology
  24. Shadows of NRF2 in cancer: Resistance to chemotherapy
    Bo-Hyun Choi, Mi‐Kyoung Kwak · 2016 · Current Opinion in Toxicology
  25. ERK and PI3K signaling cascades induce Nrf2 activation and regulate cell viability partly through Nrf2 in human glioblastoma cells
    Zixiang Cong, Handong Wang, Jiawei Wang, Yuan Zhou, Hao Pan, Ding-Ding Zhang, Lin Zhu · 2013 · Oncology Reports
  26. Hippo Pathway in Regulating Drug Resistance of Glioblastoma
    Giacomo Casati, Laura Giunti, Anna Lisa Iorio, Arianna Marturano, Luisa Galli, Iacopo Sardi · 2021 · International Journal of Molecular Sciences
  27. The Potential Role of Major Argan Oil Compounds as Nrf2 Regulators and Their Antioxidant Effects
    Riad El Kebbaj, Habiba Bouchab, Mounia Tahri-Joutey, Soufiane Rabbaa, Youness Limami, Boubker Nasser, Melford Chuka Egbujor, Paolo Tucci, Pierre Andreoletti, Luciano Saso et al. · 2024 · Antioxidants
  28. Fuzzy Complex Formation between the Intrinsically Disordered Prothymosin α and the Kelch Domain of Keap1 Involved in the Oxidative Stress Response
    Halema Khan, Elio A. Cino, Anne M. Brickenden, Jing‐Song Fan, Daiwen Yang, Wing‐Yiu Choy · 2013 · Journal of Molecular Biology
  29. Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas
    Maribel Escoll, Diego Lastra, Marta Pajares, Natalia Robledinos-Antón, Ana Isabel Rojo, Raquel Fernández-Ginés, Marta Mendiola, Virginia Martínez-Marín, I. Esteban, Pilar López‐Larrubia et al. · 2020 · Redox Biology
  30. Dual BACH1 regulation by complementary SCF-type E3 ligases
    Benedikt Goretzki, Maryam Khoshouei, Martin Schröder, Patrick Penner, Luca Egger, Christine Stephan, Dayana Argoti, Nele Dierlamm, Jimena Maria Rada, Sandra Kapps et al. · 2024 · Cell
  31. Atypical Protein Phosphatases: Emerging Players in Cellular Signaling
    Daichi Sadatomi, Susumu Tanimura, Kei‐ichi Ozaki, Kohsuke Takeda · 2013 · International Journal of Molecular Sciences
  32. The significance of gene mutations across eight major cancer types
    Prosenjit Paul, Arup Kumar Malakar, Supriyo Chakraborty · 2019 · Mutation Research/Reviews in Mutation Research
  33. Structural Basis for Recruitment of DAPK1 to the KLHL20 E3 Ligase
    Chen, Zhuoyao, Picaud, Sarah, Filippakopoulos, Panagis, D'Angiolella, Vincenzo, Bullock, Alex N. · 2019 · Structure
  34. A NRF2 inhibitor selectively sensitizes KEAP1 mutant tumor cells to cisplatin and gefitinib by restoring NRF2-inhibitory function of KEAP1 mutants
    Tahar Aboulkassim, Xiaohong Tian, Qiang Liu, Dinghong Qiu, Mark A. Hancock, Jian Hui Wu, Gerald Batist · 2023 · Cell Reports
  35. Genome-wide global identification of NRF2 binding sites in A549 non-small cell lung cancer cells by ChIP-Seq reveals NRF2 regulation of genes involved in focal adhesion pathways
    Akhileshwar Namani, Kaihua Liu, Shengcun Wang, Xihang Zhou, Yijiao Liao, Hongyan Wang, Xiu Jun Wang, Xiuwen Tang · 2019 · Aging
  36. The KEAP1/NRF2 Signaling Pathway in Keratinization
    Yosuke Ishitsuka, Tatsuya Ogawa, Dennis R. Roop · 2020 · Antioxidants
  37. Oxidative Stress-Induced Misfolding and Inclusion Formation of Nrf2 and Keap1
    Vy Ngo, Nadun C. Karunatilleke, Anne M. Brickenden, Wing‐Yiu Choy, Martin L. Duennwald · 2022 · Antioxidants
  38. Multiple binding modes of a small molecule to human Keap1 revealed by X‐ray crystallography and molecular dynamics simulation
    Mikiya Satoh, Hajime Saburi, Tomoyuki U Tanaka, Yoshinori Matsuura, Hisashi Naitow, Rieko Shimozono, Naoyoshi Yamamoto, Hideki Inoue, Noriko Nakamura, Yoshitaka Yoshizawa et al. · 2015 · FEBS Open Bio
  39. Structural basis of tRNA modification with CO2 fixation and methylation by wybutosine synthesizing enzyme TYW4†
    Yoko Suzuki, Akiko Noma, Tsutomu Suzuki, Ryuichiro Ishitani, Osamu Nureki · 2009 · Nucleic Acids Research
  40. Genetic deletion of Nrf2 promotes immortalization and decreases life span of murine embryonic fibroblasts
    Jodar, L., Mercken, E. M., Ariza, J., Younts, C., Gonzalez-Reyes, J. A., Alcain, F. J., Buron, I., de Cabo, R., Villalba, J. M. · 2011 · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
  41. A systematic molecular dynamics approach to the study of peptide Keap1–Nrf2 protein–protein interaction inhibitors and its application to p62 peptides
    Mengchen Lu, Zhenwei Yuan, Yong-Lin Jiang, Zhiyun Chen, Qidong You, Zhengyu Jiang · 2016 · Molecular BioSystems
  42. Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells
    Fraser D. Johnson, John R. Ferrarone, Alvin Liu, Christina Brandstädter, Ravi S. N. Munuganti, Dylan Farnsworth, Daniel Lu, Jennifer Luu, Tianna S. Sihota, Sophie Jansen et al. · 2022 · Cell Reports
  43. Phylogenetic, Structural and Functional Relationships between WD- and Kelch-Repeat Proteins
    Andrew M. Hudson, Lynn Cooley · 2008 · Sub-cellular biochemistry/Subcellular biochemistry
  44. Binding of disordered proteins to a protein hub
    Elio A. Cino, Ryan C. Killoran, Mikko Karttunen, Wing‐Yiu Choy · 2013 · Scientific Reports
  45. The instability of the BTB-KELCH protein Gigaxonin causes Giant Axonal Neuropathy and constitutes a new penetrant and specific diagnostic test
    Alexia Boizot, Yasmina Talmat-Amar, Deborah Morrogh, Nancy L. Kuntz, Cecile Halbert, B. Chabrol, Henry Houlden, Tanya Stojkovic, Brenda Arlene Schulman, Bernd W. Rautenstrauss et al. · 2014 · Acta Neuropathologica Communications
  46. A Complementary Chemical and Genomic Screening Approach for Druggable Targets in the Nrf2 Pathway and Small Molecule Inhibitors to Overcome Cancer Cell Drug Resistance
    James Matthews, Xiao Liang, Valerie Jean Paul, Hendrik Luesch · 2018 · ACS Chemical Biology
  47. Multiple roles of Nrf2-Keap1 signaling
    Huai Deng · 2013 · Fly
  48. The mechanistic insights of the antioxidant Keap1-Nrf2 pathway in oncogenesis: a deadly scenario
    Anirban Goutam Mukherjee, Abilash Valsala Gopalakrishnan · 2023 · Medical Oncology
  49. Importance of the Keap1-Nrf2 pathway in NSCLC: Is it a possible biomarker? (Review)
    Raúl Barrera Rodríguez · 2018 · Biomedical Reports
  50. Identification of compounds that inhibit the binding of Keap1a/Keap1b Kelch DGR domain with Nrf2 ETGE/DLG motifs in zebrafish
    Azhwar Raghunath, Nagarajan Raju, Kiruthika Sundarraj, Kavipriya Palanisamy, Ekambaram Perumal · 2019 · Basic & Clinical Pharmacology & Toxicology
  51. Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma
    Takayuki Shimizu, Ken-ichi Inoue, Hiroyuki Hachiya, Norisuke Shibuya, Taku Aoki, Keiichi Kubota · 2016 · Journal of Hepato-Biliary-Pancreatic Sciences
  52. Keap1–MCM3 interaction is a potential coordinator of molecular machineries of antioxidant response and genomic DNA replication in metazoa
    Nele Tamberg, Siret Tahk, Sandra Koit, Kersti Kristjuhan, Sergo Kasvandik, Arnold Kristjuhan, Ivar Ilves · 2018 · Scientific Reports
  53. Artemisinin resistance-associated markers in Plasmodium falciparum parasites from the China-Myanmar border: predicted structural stability of K13 propeller variants detected in a low-prevalence area
    Yan He, Susana G. Campino, Ernest Diez Benavente, David C. Warhurst, Khalid B. Beshir, Inke Nadia Diniyanti Lubis, Ana Rita Gomes, Jun Feng, Wang Jiazhi, Xiaodong Sun et al. · 2019 · PLoS ONE
  54. Posttranscriptional regulation of Nrf2 through miRNAs and their role in Alzheimer's disease
    Ravinder Kumar Kaundal, Ashok Kumar Datusalia, Shyam Sundar Sharma · 2021 · Pharmacological Research
  55. Dynamic modeling of Nrf2 pathway activation in liver cells after toxicant exposure
    Steven W. Hiemstra, Mirjam Fehling-Kaschek, Isoude A. Kuijper, Luc J. M. Bischoff, Lukas S. Wijaya, Marcus Rosenblatt, Jeroen J. Esselink, Allard van Egmond, Jornt Mos, Joost B. Beltman et al. · 2022 · Scientific Reports
  56. Structural and biochemical characterization establishes a detailed understanding of KEAP1-CUL3 complex assembly
    R.J. Adamson, N. Connor Payne, Sergio G. Bartual, Ralph Mazitschek, Alex N. Bullock · 2023 · Free Radical Biology and Medicine
  57. Nrf2 expression in endometrial serous carcinomas and its precancers.
    Ning Chen, Xiaofang Yi, Nisreen Abushahin, Shujie Pang, Donna Zhang, Beihua Kong, Wenxin Zheng · 2010 · PubMed Central
  58. Genomic and transcriptomic prognostic factors in R0 Dukes B and C colorectal cancer patients
    Elisenda Vendrell, Maria Ribas, Joan Valls, Xavier Solé, Mònica Grau, Victor Rau Moreno, Gabriel Capellá, Miguel Angel Peinado · 2007 · International Journal of Oncology
  59. Structural insights into the similar modes of Nrf2 transcription factor recognition by the cytoplasmic repressor Keap1
    Balasundaram Padmanabhan, Kit I. Tong, Akira Kobayashi, Masayuki P. Yamamoto, Shigeyuki Yokoyama · 2008 · Journal of Synchrotron Radiation
  60. Small Molecular Nrf2 Inhibitors as Chemosensitizers for Cancer Therapy
    Hongzhi Lin, Yuting Qiao, Hongyu Yang, Qin Nan, Wei Qu, Feng Feng, Wenyuan Liu, Yao Chen, Haopeng Sun · 2020 · Future Medicinal Chemistry
  61. Expression Patterns of Nrf2 and Keap1 in Ovarian Cancer Cells and their Prognostic Role in Disease Recurrence and Patient Survival
    Hye Yon Cho, Kidong Kim, Yong-Beom Kim, Haeryoung Kim, Jae Hong No · 2017 · International Journal of Gynecological Cancer
  62. Stapled Peptides as Direct Inhibitors of Nrf2-sMAF Transcription Factors
    Ramya Modi, Nicholas W. McKee, Ning Zhang, Amir A. Alwali, Samantha L. Nelson, Aditi Lohar, Raluca Ostafe, Donna D. Zhang, Elizabeth I. Parkinson · 2023 · Journal of Medicinal Chemistry
  63. Impact of Co-mutations and Transcriptional Signatures in Non–Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial
    Marcelo Vailati Negrao, Alvaro G. Paula, David P. Molkentine, Laura D. Hover, Monique B. Nilsson, Natalie I. Vokes, Lars D. Engstrom, Andrew Calinisan, David M. Briere, Laura M. Waters et al. · 2025 · Clinical Cancer Research
  64. Feedback loop between p66Shc and Nrf2 promotes lung cancer progression
    Wei Du, Yuan Jiang, Zhichao Zheng, Zhenfa Zhang, Na Chen, Zhenyi Ma, Zhi Yao, Lance S. Terada, Zhe Liu · 2013 · Cancer Letters
  65. Cullin 3 and Its Role in Tumorigenesis
    Ruey‐Hwa Chen · 2020 · Advances in experimental medicine and biology
  66. Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interaction
    Stefania Colarusso, Daniele De Simone, Tommaso Frattarelli, Matteo Andreini, Mauro Cerretani, Antonino Missineo, Daniele Moretti, Sara Tambone, Georg Kempf, Martin A. Augustin et al. · 2020 · Bioorganic & Medicinal Chemistry
  67. Halogens effect on spectroscopy, anticancer and molecular docking studies for platinum complexes
    Hunar Hama Khalid, Sultan Erkan, Niyazi Bulut · 2021 · Optik
  68. Dual role of Nrf2 in cancer: molecular mechanisms, cellular functions and therapeutic interventions
    M Poornashree, Hitesh Kumar, RAMKISHAN AJMEER, Rupshee Jain, Vikas Kumar Jain · 2022 · Molecular Biology Reports
  69. Analysis of dimerization of BTB-IVR domains of Keap1 and its interaction with Cul3, by molecular modeling
    Nandini Chauhan, Lata Chaunsali, Prashant H. Deshmukh, Balasundaram Padmanabhan · 2013 · Bioinformation
  70. Investigation of the intermolecular recognition mechanism between the E3 ubiquitin ligase Keap1 and substrate based on multiple substrates analysis
    Zhengyu Jiang, Lili Xu, Mengchen Lu, Yang Pan, Hao‐Ze Huang, Xiaojin Zhang, Hao-Peng Sun, Qidong You · 2014 · Journal of Computer-Aided Molecular Design
  71. The role of thioredoxin reductase 1 in melanoma metabolism and metastasis
    Pamela B. Cassidy, Matthew Honeggar, Robyn L. Poerschke, Karen H. White, Scott R. Florell, Robert H.I. Andtbacka, Joycelyn Tross, Madeleine Anderson, Sancy Ann Leachman, Philip J. Moos · 2015 · Pigment Cell & Melanoma Research
  72. Gene regulatory effects of disease-associated variation in the NRF2 network
    Sarah E. Lacher, Matthew G. Slattery · 2016 · Current Opinion in Toxicology
  73. Perspectives on the Clinical Development of NRF2-Targeting Drugs
    Diego Lastra, Raquel Fernández-Ginés, Gina Manda, Antonio Cuadrado · 2020 · Handbook of experimental pharmacology
  74. Channeling macrophage polarization by rocaglates increases macrophage resistance to Mycobacterium tuberculosis
    Sujoy Chatterjee, Shivraj M. Yabaji, Oleksii S. Rukhlenko, Bidisha Bhattacharya, Emily Waligurski, Nandini Vallavoju, Somak Ray, Boris Ν. Kholodenko, Lauren E. Brown, Aaron B. Beeler et al. · 2021 · iScience
  75. An updated patent review of Nrf2 activators (2020-present)
    Ziquan Zhao, Ruitian Dong, Keni Cui, Qidong You, Zhengyu Jiang · 2023 · Expert Opinion on Therapeutic Patents
  76. Correlation of Nrf2 and HIF-1α in glioblastoma and their relationships to clinicopathologic features and survival
    Xiangjun Ji, Handong Wang, Jianhong Zhu, Yong Tang, Yuan Zhou, Lin Zhu, Chao-Chao Gao, Wei Li, Wanchun You, Bo Yu et al. · 2013 · Neurological Research
  77. Actin Cytoskeletal Organization in Drosophila Germline Ring Canals Depends on Kelch Function in a Cullin-RING E3 Ligase
    Andrew M. Hudson, Katelynn M. Mannix, Lynn Cooley · 2015 · Genetics
  78. GRP78 effectively protect hypoxia/reperfusion‐induced myocardial apoptosis via promotion of the Nrf2/HO‐1 signaling pathway
    Heyu Ji, Feng Xiao, Suobei Li, Ruan Wei, Fei Yu, Junmei Xu · 2020 · Journal of Cellular Physiology
  79. Medicinal Chemistry Insights into the Development of Small-Molecule Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Protein–Protein Interaction Inhibitors
    Ziquan Zhao, Ruitian Dong, Qidong You, Zhengyu Jiang · 2023 · Journal of Medicinal Chemistry
  80. Nrf2 expression is associated with poor outcome in osteosarcoma
    Jae Young Park, Youn Wha Kim, Yong-Koo Park · 2012 · Pathology
  81. Regulation of stress signaling pathways by nitro-fatty acids
    Ashik Jawahar Deen, Virve Sihvola, Jouni Härkönen, Tommi Patinen, Simone Adinolfi, Anna–Liisa Levonen · 2018 · Nitric Oxide
  82. Targeting the Metabolic Paradigms in Cancer and Diabetes
    Mira Bosso, Dania Haddad, Ashraf Said Al Madhoun, Fahd Al‐Mulla · 2024 · Biomedicines
  83. Advances in KEAP1-based PROTACs as emerging therapeutic modalities: Structural basis and progress
    Jing Chen, Disheng Feng, Rui Zhu, Hua Li, Lixia Chen · 2025 · Redox Biology
  84. NRF2 level is negatively correlated with TGF-β1-induced lung cancer motility and migration via NOX4-ROS signaling
    Da-Young Ryu, Jinhee Lee, Mi‐Kyoung Kwak · 2020 · Archives of Pharmacal Research
  85. Novel NRF2 ‐activated cancer treatments utilizing synthetic lethality
    Liam Baird, Thomas W. Kensler, Masayuki P. Yamamoto · 2022 · IUBMB Life
  86. NRF2 in dermo‐cosmetic: From scientific knowledge to skin care products
    Marie‐Céline Frantz, Roger Rozot, Laurent Marrot · 2022 · BioFactors
  87. Rational and experimental investigation of antihypotensive midodrine-Fe(III) complex: Synthesis, spectroscopy, DFT, biological activity and molecular docking
    Doaa S. El‐Sayed, Tarek E. Khalil, Hemmat A. Elbadawy · 2024 · Journal of Molecular Structure
  88. NRF2: Master regulator of cellular homeostasis and therapeutic vulnerability in cancer
    Wei-Tai Chen, Nicholas W. McKee, Damaris Kuhnell, Matthew B. Dodson · 2026 · Redox Biology
  89. The E3-ome gene-centric compendium reveals the human E3 ligase landscape
    Ngee Kiat Chua, Tania J González-Robles, Cameron J. Reddington, Jane Dudley-Fraser, Richard W. Birkinshaw, Jiru Han, Ashleigh N. Solano, Soon Wei Wong, Tomasz Kochańczyk, Joshua J. Peter et al. · 2026 · Cell
  90. The C-Terminal Domain of Nrf1 Negatively Regulates the Full-Length CNC-bZIP Factor and Its Shorter Isoform LCR-F1/Nrf1β; Both Are Also Inhibited by the Small Dominant-Negative Nrf1γ/δ Isoforms that Down-Regulate ARE-Battery Gene Expression
    Yiguo Zhang, Lu Qiu, Shaojun Li, Yuancai Xiang, Jiayu Chen, Yonggang Ren · 2014 · PLoS ONE
  91. The comparison of neuroprotective effects of isoliquiritigenin and its Phase I metabolites against glutamate-induced HT22 cell death
    Eun Ju Yang, Minjun Kim, Ji Eun Woo, Tae‐Ho Lee, Jong‐Wha Jung, Kyung‐Sik Song · 2016 · Bioorganic & Medicinal Chemistry Letters
  92. Simultaneous Activation of Nrf2 and Elevation of Dietary and Endogenous Antioxidant Chemicals for Cancer Prevention in Humans
    Kedar Nath Prasad · 2015 · Journal of the American College of Nutrition
  93. Mechanisms Underlying Chemopreventive Effects of Flavonoids via Multiple Signaling Nodes within Nrf2-ARE and AhR-XRE Gene Regulatory Networks
    Han Xiao, Feng-Lin Lu, Derek Stewart, Yiguo Zhang · 2013 · Current Chemical Biology
  94. Adenovirus-Mediated Over-Expression of Nrf2 Within Mesenchymal Stem Cells (MSCs) Protected Rats Against Acute Kidney Injury
    Mohammad Mohammadzadeh-Vardin, Mehryar Habibi Roudkenar, Ali Jahanian‐Najafabadi · 2015 · Advanced Pharmaceutical Bulletin
  95. Abrus agglutinin inhibits oral carcinogenesis through inactivation of NRF2 signaling pathway.
    Debasna P Panigrahi, C. S. Bhol, Niveta R, S. Nagini, S. Patil, T. K. Maiti, S. Bhutia · 2019 · International Journal of Biological Macromolecules
  96. Dual Protective Effects of Flavonoids from Petasites japonicus against UVB-Induced Apoptosis Mediated via HSF-1 Activated Heat Shock Proteins and Nrf2-Activated Heme Oxygenase-1 Pathways
    Ki Mo Kim, A‐Rang Im, Sanghyun Lee, Sungwook Chae · 2017 · Biological and Pharmaceutical Bulletin
  97. Ponicidin Promotes Hepatocellular Carcinoma Mitochondrial Apoptosis by Stabilizing Keap1‐PGAM5 Complex
    Bixin Zhao, Zuhui Liang, Lisheng Zhang, Lin Jiang, Yuanhang Xu, Ying Zhang, Rong Zhang, Caiyan Wang, Zhongqiu Liu · 2024 · Advanced Science
  98. Emerging role of nuclear factor erythroid 2-related factor 2 in the mechanism of action and resistance to anticancer therapies
    P. Poornima, Ibrahim Hamza Kankia, Simon P. Langdon, Yusuf Deeni · 2019 · Cancer Drug Resistance
  99. The impact of mitochondria on cancer treatment resistance
    Michelle van der Merwe, Gustav van Niekerk, Carla Fourie, Manisha du Plessis, Anna‐Mart Engelbrecht · 2021 · Cellular Oncology
  100. Role of 17β-Estradiol on Cell Proliferation and Mitochondrial Fitness in Glioblastoma Cells
    Carlo Castruccio Castracani, Lucia Longhitano, Alfio Distefano, Carmelina Daniela Anfuso, Stavroula Kalampoka, Enrico La Spina, Marinella Astuto, Roberto Avola, Massimo Caruso, Daria Nicolosi et al. · 2020 · Journal of Oncology